CEACAM5 and colorectal carcinoma: Therefore, we recommend using CEA in conjunction with other indicators, such as the platelet-to-lymphocyte ratio (PLR), to enhance diagnostic accuracy and provide a more comprehensive evaluation of PNI risk in CRC patients.